The name Rain Therapeutics Inc. (RAIN) should be kept on your radar

In the latest session, Rain Therapeutics Inc. (NASDAQ: RAIN) closed at $8.00 down -5.66% from its previous closing price of $8.48. In other words, the price has decreased by -$0.48 from its previous closing price. On the day, 122771 shares were traded. RAIN stock price reached its highest trading level at $8.78 during the session, while it also had its lowest trading level at $7.97.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



For a deeper understanding of Rain Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.20 and its Current Ratio is at 7.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 12, 2022, initiated with a Buy rating and assigned the stock a target price of $10.

On April 01, 2022, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $15.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 22 when BERGER FRANKLIN M bought 77,000 shares for $8.27 per share. The transaction valued at 636,790 led to the insider holds 1,005,207 shares of the business.

BERGER FRANKLIN M bought 45,000 shares of RAIN for $351,000 on Nov 21. The Director now owns 928,207 shares after completing the transaction at $7.80 per share. On Nov 08, another insider, BERGER FRANKLIN M, who serves as the Director of the company, bought 42,881 shares for $5.83 each. As a result, the insider paid 249,996 and bolstered with 883,207 shares of the company.

Stock Price History:

Over the past 52 weeks, RAIN has reached a high of $15.08, while it has fallen to a 52-week low of $2.15. The 50-Day Moving Average of the stock is 5.74, while the 200-Day Moving Average is calculated to be 5.32.

Shares Statistics:

For the past three months, RAIN has traded an average of 60.32K shares per day and 128.75k over the past ten days. A total of 26.57M shares are outstanding, with a floating share count of 23.44M. Insiders hold about 15.50% of the company’s shares, while institutions hold 61.70% stake in the company. Shares short for RAIN as of Oct 13, 2022 were 261.57k with a Short Ratio of 0.27M, compared to 284.28k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.98% and a Short% of Float of 4.00%.

Earnings Estimates

There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.68 for the current quarter, with a high estimate of -$0.65 and a low estimate of -$0.73, while EPS last year was -$0.7. The consensus estimate for the next quarter is -$0.65, with high estimates of -$0.59 and low estimates of -$0.71.

Analysts are recommending an EPS of between -$2.59 and -$2.72 for the fiscal current year, implying an average EPS of -$2.65. EPS for the following year is -$2.33, with 7 analysts recommending between -$1.9 and -$2.54.